BCL11A_chipseq_in_TNBC-sc-3969
BCL11A_chipseq_in_TNBC
I will be performing Chipseq experiments to identify where in the genome does BCL11A bind. To achieve this we will use triple-negative breast cancer (TNBC) cell lines to perform these experiments. This work is complimentary to the mouse works also done in collaboration with Pentao on the biological role of BCL11A in TNBC.   This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria), please see http://www.sanger.ac.uk/datasharing/
I will be performing Chipseq experiments to identify where in the genome does BCL11A bind. To achieve this we will use triple-negative breast cancer (TNBC) cell lines to perform these experiments. This work is complimentary to the mouse works also done in collaboration with Pentao on the biological role of BCL11A in TNBC.